Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Alzheimer’s disease researchers makes significant breakthroughs

Researchers in Sweden and United Kingdom have made a breakthrough in Alzheimer’s disease research. They could soon be on the path to develop new drugs that could fight the disease more effectively.

26 Sep 2018

UCI study finds new cause of cerebral microbleeds

A team of researchers including UCI project scientist Rachita Sumbria, PhD and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear.

25 Sep 2018

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

New research conducted at the Lady Davis Institute at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology in an animal model.

25 Sep 2018

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.

25 Sep 2018

Charity urges government to increase financial support for dementia research

Alzheimer’s Research UK, one of the top dementia research funders in the world, is calling on the UK government to adopt a bold new action plan to bring about a life-changing dementia treatment and improve the lives of people with the condition.

25 Sep 2018

Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson's disease

The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibers responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease.

25 Sep 2018

Study explores link between genetic predisposition to Alzheimer's and cardiometabolic risk factors

Alzheimer's disease is the most common memory disorder. In addition to genetic predisposition, the risk of Alzheimer's disease is also increased by cardiometabolic risk factors, such as type 2 diabetes. The accumulation of these risk factors is known as the metabolic syndrome.

25 Sep 2018

Physical activity may have beneficial effects for people with rare Alzheimer's disease

For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may delay cognitive decline, according to a new study available online by Alzheimer's & Dementia: The Journal of the Alzheimer's Association as an article in press, corrected proof.

25 Sep 2018

Toxicological evaluation and dosimetry estimation of potential PET radiotracer

The SR101 N-(3-[18F]Fluoropropyl) sulfonamide ([18F]SRF101) is a Sulforhodamine 101 derivative that was previously synthesized by our group.

25 Sep 2018

New research finds link between impaired vision, hearing, and cognition

Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institute on Aging hope their work--reported today in the Journal of the American Geriatrics Society--will have colleagues seeing eye-to-eye on an important but under-researched area of health care: The link between impaired vision, hearing, and cognition

25 Sep 2018

Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer's disease

USC scientists say Alzheimer's could be diagnosed earlier if scientists focus on an early warning within the brain's circulation system.

25 Sep 2018

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

The number of people suffering from respiratory indications and the severity of those already suffering from the various diseases is expected to increase if air pollution in the UK goes unchecked, says GlobalData, a leading data and analytics company.

24 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Place where older adults live before hospitalization may affect risk of readmission

Forty per cent of older adults who leave hospital are discharged to home care or a long-term care facility, which, combined with where they lived before hospitalization, affects their risk of readmission, found a study published in CMAJ.

24 Sep 2018

Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s

Cytox, a precision medicine company which today is commercializing polygenic risk scoring approaches for assessing genetic risk for developing Alzheimer's disease and other neurological diseases, has announced it has expanded its research collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing to test new algorithms for identifying the pre-symptomatic and mild cognitively impaired people most at risk to progress to AD.

24 Sep 2018

Study sheds light on molecular mechanisms underlying progression of prion diseases

A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

21 Sep 2018

Survey estimates caregiving costs for family members

"Informal care" is the term used in medicine to describe unpaid care provided by family and friends. It's an important lifeline for millions of older adults in the U.S. who need day-to-day help with shopping, cooking, cleaning, eating, taking medicine, looking after their own daily well-being, and many other activities essential to our health and quality of life as we age.

21 Sep 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Alzheimer’s disease researchers makes significant breakthroughs

UCI study finds new cause of cerebral microbleeds

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Charity urges government to increase financial support for dementia research

Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson's disease

Study explores link between genetic predisposition to Alzheimer's and cardiometabolic risk factors

Physical activity may have beneficial effects for people with rare Alzheimer's disease

Toxicological evaluation and dosimetry estimation of potential PET radiotracer

New research finds link between impaired vision, hearing, and cognition

Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer's disease

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Place where older adults live before hospitalization may affect risk of readmission

Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s

Study sheds light on molecular mechanisms underlying progression of prion diseases

Survey estimates caregiving costs for family members

USC research uncovers previously unknown genetic risk factor for dementia

Study explores connection between sexuality and cognitive status in older adults

Air pollution appears to be linked to increased risk of developing dementia

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in